Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Biocardia Inc. buy me8

Start price
€0.81
15.11.23 / 0%
Target price
-
15.11.24
Performance (%)
-56.52%
End price
-
16.11.24
Summary
This prediction is currently being closed. Massive losses of -56.52% have been the result for the BUY prediction by me8. This prediction was marked as speculative and is excluded from me8's performance statistics.
Performance without dividends (%)
Name 1w 1m 1y
Biocardia Inc. - - -
iShares Core DAX® -1.212% 1.925% 17.589%
iShares Nasdaq 100 -4.714% -1.810% 0.450%
iShares Nikkei 225® -2.976% -2.660% 10.156%
iShares S&P 500 -2.744% -0.448% 0.320%

According to me8 what are the pros and cons of Biocardia Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Capable Management
Differentiated customer and product portfolio
Cons
high free float

Comments by me8 for this prediction

In the thread Biocardia Inc. diskutieren

Buy Biocardia Inc.

In the thread Trading Biocardia Inc.
Prediction Buy
Perf. (%) -56.52%
Target price
Change
Ends at 15.11.24

Die von me8 gewählte maximale Laufzeit wurde überschritten

Stopped prediction by me8 for Biocardia Inc.

buy
Biocardia Inc.

Start price
Target price
Perf. (%)
€4.53
14.12.20
€5.00
14.12.21
-24.50%
29.01.21

Could be worthwhile Investment >10% per year
Capable Management
Differentiated customer and product portfolio
high free float